JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
JAMP PHARMA CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE 150MG 12.5MG has been permanently discontinued (last updated April 7, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02418223
Strength
150MG 12.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
IRBESARTAN HYDROCHLOROTHIAZIDE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164